Specialists for Epstein-Barr virus-associated malignant lymphoproliferative disorder

26 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

David Maloney
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
PI×11
Mitchell Cairo, MD, MD
Rare Disease / Clinical Research
New York Medical College
HAWTHORNE, NY
PI×11
Colleen Delaney, MD
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
OLD GREENWICH, CT
PI×3
Bilal Omer, MD, MD
Rare Disease / Clinical Research
Baylor College of Medicine
HOUSTON, TX
PI×3
Paul Martin
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
PI×3 73
Philip L. McCarthy, MD
Rare Disease / Clinical Research
Roswell Park Cancer Institute
PI×7
Nathaniel Treister, MD, DMD, DMSc
Rare Disease / Clinical Research
Children's Oncology Group
LEBANON, NH
PI×1
Hongtao Liu
Rare Disease / Clinical Research
University of Chicago Comprehensive Cancer Center
MADISON, WI
PI×4
Paul Carpenter, MD
Rare Disease / Clinical Research
Fred Hutchinson Cancer Center
PI×2
Mary Laughlin, MD
Rare Disease / Clinical Research
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
PI×1
Kenneth G. Lucas, MD
Rare Disease / Clinical Research
Milton S. Hershey Medical Center
PI×7
Brian Hill, MD
Rare Disease / Clinical Research
Case Comprehensive Cancer Center
PI×1
Don Diamond, PhD
Rare Disease / Clinical Research
City of Hope Medical Center
PI×1
Ann Woolfrey, M.D
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
SEATTLE, WA
PI×5
Minoti Hiremath, MD
Rare Disease / Clinical Research
Atara Biotherapeutics
PI×2
Jiexian Ma
Huadong Hospital
QC-verified PI×1
Linda J. Burns
Masonic Cancer Center, University of Minnesota
QC-verified PI×3
Jack D. Burton
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
QC-verified PI×3
Brian J. Bolwell, md
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
CLEVELAND, OH
QC-verified PI×3
Jakob Dupont, MD
Memorial Sloan Kettering Cancer Center
SOUTH SAN FRANCISCO, CA
QC-verified PI×2
Bente Jespersen
Aarhus University Hospital
QC-verified PI×1
Steven C. Goldstein
H. Lee Moffitt Cancer Center and Research Institute
QC-verified PI×4
Roger Dansey
Barbara Ann Karmanos Cancer Institute
QC-verified PI×1
Christos E. Emmanouilides, MD
Jonsson Comprehensive Cancer Center
LOS ANGELES, CA
QC-verified PI×7
Daniel J. Weisdorf, MD
Masonic Cancer Center, University of Minnesota
MINNEAPOLIS, MN
QC-verified PI×6
Karen S. Slobod, MD
St. Jude Children's Research Hospital
MEMPHIS, TN
QC-verified PI×1

More about Epstein-Barr virus-associated malignant lymphoproliferative disorder